Nicolas Lafont focuses his practice on cross-border mergers and acquisitions, joint-venture transactions, corporate reorganizations and general corporate and commercial representation. He has led transactions in a wide range of sectors, including energy, pharmaceuticals, medical devices, semiconductor equipment, software, technology, the automotive industry, chemicals and manufacturing.
Nicolas is admitted to practice in Paris, New York and Madrid. His transactional experience extends to various countries in America, Asia and Europe.
- Represented a French leading audit firm in the structuring and implementation of its alliance with five audit firms in North America.
- Represented a European car part manufacturer in its joint venture with a major French car manufacturer for the production of electrical transmissions.
- Represented a leading Italian pharmaceutical company in its EUR90 million acquisition of a French company active in the self-medication market.
- The Best Lawyers in France, Insolvency & Reorganization Law, 2024
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2024
- The Legal 500 EMEA, Recommended, 2022
- IFLR1000, M&A, 2022-2023
- Le Magazine des Affaires, rising star of the French M&A legal market, 2013
- International Bar Association, M&A and Latin America sections
- University of Arizona James E. Rogers College of Law, LLM, International Trade Law
- Université Lille II, Master’s Degree, European Business Law
- Paris
- New York
- Madrid
- English
- French
- Spanish

Théophile Jomier
Théophile Jomier focuses his practice on complex corporate transactions, in particular, on restructurings and refinancings. He has a wealth of experience in financial and commercial disputes and a strong background in international finance.
Prior to joining McDermott Will & Schulte, Théophile spent several years at an elite restructuring and insolvency law firm.
- Legal 500 EMEA, Recommended (2022-2024), Next Generation Partner, 2025-2026
- The Best Lawyers in France, “Ones to Watch”, 2024-2026
- IFLR 1000, Rising Star, Restructuring & Insolvency, 2024
- King’s College London, LLM
- Paris 1 Panthéon-Sorbonne University, MA, Business Law
- Paris
- English
- French

Diana Hund
Diana Hund advises clients on a wide variety of corporate transactions, including domestic and cross-border mergers and acquisitions, and leveraged buyouts.
- The Legal 500 EMEA, Leading Partner in France: Private Equity: LBO, 2025-2026
- Chambers France, Band 3 in Private Equity: Mid-Market, 2026
- Chambers Europe, France: Private Equity: Mid-Market, 2023- 2024
- The Legal 500 EMEA, Next Generation Partner in France: Private Equity: LBO, 2023-2024
- The Best Lawyers in France, 2022-2026
- Chambers Europe, Private Equity, 2016
- University of Paris Ouest Nanterre La Défense, Master’s Degree, European Business Law
- Paris 1 Panthéon-Sorbonne University, LLM (Köln/Paris I)
- Double Degree in French and German Laws
- Paris
- English
- French
- German

Mandy H. Kim
Mandy H. Kim is a high-performing and zealous patent trial lawyer and litigator. She has extensive experience in managing complex, bet-the-company litigations across a wide range of technologies, including in the life sciences, biotechnology, medical devices, computer hardware and software, and consumer electronics industries. Mandy has led teams in all stages of litigation from pre-suit investigations through trial and appeals. She has an impressive record in achieving favorable results for her clients in district courts, the Patent Trial and Appeal Board and the International Trade Commission.
- Successfully obtained a jury trial win in favor of Natera Inc. in a patent infringement case involving novel methods of preparing DNA/RNA. (Natera, Inc. v. ArcherDX, Inc. et al.)
- Secured a trial win in favor of United Therapeutics Corporation on a patent relating to methods of treating pulmonary hypertension in which the US District Court for the District of Delaware found United Therapeutics’ patent infringed and valid. (United Therapeutics Corp. v. Liquidia Techs., Inc.)
- Obtained a favorable settlement on behalf of Aurinia Pharmaceuticals in a patent litigation involving novel pharmaceutical drugs for dry eye disease. (Aurinia Pharmaceuticals Inc. v. Sun Pharmaceutical Industries, Inc. et al.)
- Legal 500 USA, Recommended Lawyer, 2022
- IAM Patent 1000 – The World’s Leading Patent Practitioners, 2023-2025
- Orange County Business Journal, Leaders of Influence: Women in Law, 2024
- Super Lawyers, Southern California Rising Stars, 2014-2019
- Public Law Center, board of directors
- Pepperdine Dean’s Council, member
- Orange County Korean American Bar Association, president-elect
- International Association of Korean Lawyers, Orange County regional governor
- National Asian Pacific American Bar Association, member
- Leadership Council on Legal Diversity, 2020 fellow
- Orange County Coalition for Diversity in the Law, former co-chair
- Pepperdine University School of Law, JD, Microbiology, cum laude
- University of California, Los Angeles, MS, Immunology and Molecular Genetics
- University of California, Los Angeles, BS, Microbiology
- Immunology and Molecular Genetics
- California
- US Court of Appeals for the Federal Circuit
- English
- Korean

Sarah Bro
Sarah Bro focuses her practice on trademark prosecution, enforcement, and brand portfolio management, as well as licensing, due diligence, copyright, right of publicity, and domain name matters.
- Advised on the strategic re-branding of a pioneering medical real estate and physician practice solution company as a key aspect of a private-equity investment
- Negotiated the brand license and coexistence terms of an acquisition by a private equity-backed strategic buyer of an innovative concierge medicine system
- Comprehensive management of global trademark portfolios for Fortune 100 and international clients in a wide array of industries
- Chambers USA, Band 1 in Intellectual Property: Trademark and Copyright & Trade Secrets: Transactional, 2022-2026
- The Legal 500 USA, Recommended Lawyer, 2022-2025
- Managing Intellectual Property, IP Stars, Trade mark Star and Copyright Star, 2025-2026
- JD Supra, Readers’ Choice Awards, Top Author – Trademarks, 2021-2024
- Common Threads, Golden Heart Honoree, 2024
- Orange County Business Journal, Leaders of Influence: Women in Law, 2024
- Lexology, Legal Influencers Q1, 2021
- World Trademark Review 1000, Leading Trademark Practitioner, 2020-2023
- Orange County Intellectual Property Law Association, board member
- Whittier Law School Alumni Association, board member and bar prep mentorship coordinator
- International Trademark Association (INTA), Law Firm Committee vice chair, former Culture Subcommittee Leader; recognized as a high-performing committee member, 2023
- Whittier Law School, JD, Outstanding Fellow for Intellectual Property, summa cum laude,
- Western Michigan University, BA, summa cum laude
- California
- US Patent and Trademark Office
- English

Herschel Guez
Herschel Guez focuses on domestic and international mergers and acquisitions, particularly on leveraged buyouts and other private equity transactions. He advises French and international companies, private equity funds, founders and managers on acquisition, fund raising and disposal transactions.
Prior to joining the firm, Herschel was an associate at other leading international law firms.
- Best Lawyers in France: Ones to Watch, 2022 – 2025
- École Supérieure de Commerce de Paris (ESCP), Master’s, International Business Law and Management
- Jean Moulin Lyon 3 University
- Paris 1 Panthéon-Sorbonne University
- Paris 1 Panthéon-Sorbonne University
- Paris 1 Panthéon-Sorbonne University
- Paris
- English
- French
- Hebrew

Timothée Gagnepain
Timothée Gagnepain focuses his practice on complex restructurings and insolvencies, both national and international. Timothée has a broad-based insolvency and restructuring practice, representing mainly debtors, shareholders, private equity funds, some creditors and trustees. He acts as strategic advisor, negotiator and, when necessary, litigation counsel, and has significant experience before the French bankruptcy courts.
- The Legal 500 EMEA, Leading Individual in France: Insolvency, 2025-2026
- Chambers France, Band 3 Restructuring/Insolvency, 2026
- Chambers Europe, France: Restructuring & Insolvency, 2022-2024
- The Best Lawyers in France, Insolvency and Reorganization Law, 2020-2026
- Thomson Reuters Stand-out Lawyers, Independently rated lawyers, 2022-2026
- Global Restructuring Review GRR 30, Recommended, 2024-2025
- Global Restructuring Review GRR 100, Recommended, 2023
- Association pour le Retournement des Enterprises (ARE), member
- L’Institut Français des Praticiens des Procédures Collectives (IFPPC), member
- Association des Investisseurs en Retournement
- Columbia Law School, LLM
- Paris-Panthéon-Assas University, DESS
- Paris-Panthéon-Assas University, JD
- New York
- Paris
- English
- French

Eric Zimmerman
Eric Zimmerman is a recognized Medicare law and policy authority and registered lobbyist who represents clients before Congress and administrative agencies, and helps clients navigate federal legislative and regulatory processes related to Medicare coverage, coding, reimbursement and compliance. He primarily counsels and represents hospitals and health systems, ambulatory surgery centers, clinical laboratories, pharmaceutical, biotechnology and device manufacturers and suppliers, medical trade associations and professional societies.
- Representing some of the country’s largest health systems and service providers, diagnostics companies, and pharmaceutical and device manufacturers before the US Congress, the Department of Health and Human Services, Centers for Medicare and Medicaid Services, and other federal agencies
- Advancing legislative and regulatory changes achieving Medicare coverage, improving reimbursement, and revising regulatory obligations
- Developing and implementing lobbying strategies, and forming and managing advocacy coalitions
- Providing financial analysts and investors with specialized due diligence to understand the implications of federal legislative and regulatory developments, and evaluate investments in health care companies
- Representing providers before the Provider Reimbursement Review Board, Medicare Geographic Classification Review Board, administrative law judges and federal courts
- Best Lawyers in America, Healthcare Law, 2014-2027
- Best Lawyers in America, Lawyer of the Year in Washington, DC: Healthcare Law, 2020, 2024 and 2026
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2023-2026
- Chambers USA, Healthcare, Band 1, 2006-2023; Band 2, 2024-2026
- Legal 500 US, Recommended, 2011, 2020, 2022 and 2024
- American Health Law Association (AHLA), fellow
- George Mason University Antonin Scalia Law School, JD
- George Washington University, MBA
- Emory University, BA
- District of Columbia
- Maryland
- English

Daniel L. Woodard
Daniel (Dan) Woodard counsels public and private companies on raising capital, business combinations, corporate governance and general corporate matters. He focuses his practice on representing private and public companies in all aspects of public and private securities offerings, mergers and acquisitions, public company reporting and disclosure compliance and stock exchange-listing compliance. He also advises fintech companies with regard to the application of securities laws to blockchain and cryptocurrency assets.
- Represented Tether, the issuer of the world’s largest stablecoin, in:
- Its tender offer and acquisition of a 70% interest in Adecoagro S.A. (NYSE: AGRO), a leading sustainable production company in South America, for approximately $615.5 million
- Its $775 million strategic private investment in public equity (PIPE) investment in Rumble (NASDAQ: RUM), a leading video sharing platform and cloud services provider
- Its sale of its majority stake in Northern Data AG, a provider of AI and high-performance computing (HPC) infrastructure, to Rumble (NASDAQ: RUM)
- Represented AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of body contouring procedures under the brand Elite Body Sculpture, and AirSculpt’s majority stockholder Vesey Street Capital Partners in AirSculpt’s $90 million initial public offering
- Represented INX Limited, a security token and digital asset trading platform, US broker-dealer, alternative trading system, and transfer agent, in its $85 million registered offering of the INX Token, which was the first public offering of a security token registered with the US Securities and Exchange Commission
- Legal 500 US, Recommended, 2025
- The Best Lawyers: Ones to Watch in America, Corporate Law, 2024-2025
- Law360, Capital Markets Editorial Advisory Board, 2024 and 2026
- Georgetown University Law Center, JD, cum laude
- University of California, Berkeley, BA
- New York
- District of Columbia
- English
- Korean

Michael J. Wilder
Michael J. Wilder focuses his practice on corporate and international tax issues. He has extensive experience in structuring corporate mergers and dispositions, spin-offs, liquidations, cross-border transfers and financing instruments, as well as in the areas of consolidated returns, bankruptcy and insolvency tax matters. Michael represents clients in seeking private letter rulings from the Internal Revenue Service (IRS) and in handling audit and appeals matters. Michael is the leader of McDermott’s Corporate Tax Practice.
- Advised clients with respect to a number of the largest transactions in the public markets over the last five years, including the following:
- Spin-offs involving Fortune 50 and Fortune 100 companies
- Redomicile transactions involving Fortune 50 and Fortune 100 companies
- Domestic and cross-border mergers involving Fortune 50 companies
- Chambers USA, Tax, 2023–2025
- Legal 500 US, Recommended, 2019–2025
- International Review Tax, World Tax, 2017 and 2026
- Turnaround & Workouts, Bankruptcy Tax Specialists in the Nation’s Major Law Firms, 2022-2026
- University of Michigan Law School, JD
- Yale University, BA
- District of Columbia
